This barrier is unrelated to the end of the transition period, following the United Kingdom's departure from the EU.

Public ID: PID-94YRRB

Restriction on exporting pharmaceuticals to Bangladesh

in Bangladesh

Trade barrier summary

This affects UK exporters of pharmaceutical products to Bangladesh. Prior approval from the Directorate General of Drug Administration (DGDA) of the Ministry of Health and Family Welfare is required to export pharmaceutical products to Bangladesh. The importer, along with the other details of the drug, needs to submit the intended quantity of import for approval - the quantity is often dictated by the demand for that specific brand in the market.

Recently DGDA has been approving significantly lower quantities than requested, which is creating a problem for importers. Restricting the quantity that can be imported means unmet demand remains in the market, and market shortages affect consumer trust in the brand.

Sectors affected

  • Pharmaceuticals and biotechnology



Date reported

23 May 2019

Last updated

18 December 2020

Public ID


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.